跳至主要内容
临床试验/IRCT20210620051629N1
IRCT20210620051629N1招募中3 期

The assessment of curcumin in comparison with placebo on the auditory neuropathy in chronic kidney disease and diabetes mellitus patients

Shiraz University of Medical Sciences0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 50 years(—)
性别
All

入选标准

  • All chronic kidney and diabetic patients with definitive diagnosis of nephrologist and endocrinologist who have been ill for more than 6 months
  • All patients with chronic renal disease and diabetes with definitive diagnosis who have hearing impairment in the initial evaluation
  • All chronic renal and diabetic patients with definitive diagnosis with glomerular filtration rate less than 60

排除标准

  • Use of aspirin and warfarin
  • Mental diseases
  • Usage of other complementary medicine methods
  • Usage of other antioxidant drugs except Nephrovit pills
  • Having gallstones

研究者

相似试验